NCT01485393View on ClinicalTrials.gov

Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 29, 2018

Study Completion Date

June 29, 2018

Conditions
Insomnia
Interventions
DRUG

Dexmedetomidine

A dose of dexmedetomidine will be administered at 1mcg/kg over 10 minutes. Subjects will never receive active drugs (Zolpidem or dexmedetomidine concurrently).

DRUG

Zolpidem

12.5 mg of oral Ambien CR. Subjects will never receive active drugs (Zolpidem/Ambien or dexmedetomidine concurrently).

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT01485393 - Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep | Biotech Hunter | Biotech Hunter